Accelmed Partners
Private equityMiami · Pre-Seed–Late Stage · 10 people tracked
Also known as ACCELMED PARTNERS II MANAGEMENT, LLC
Find your way into Accelmed Partners
867 people in our graph share verified history with the Accelmed Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Accelmed Partners invests in healthcare technology companies, taking a private equity approach to a market historically dominated by venture and early-stage growth firms. The firm works closely with portfolio company management to improve operations, refresh product portfolios, and strengthen commercial organizations, providing hands-on support and resources. Its focus areas span tools and diagnostics, digital health, and tech-enabled healthcare services, positioning itself as a leader in healthcare technology investing.
Source: firm website, verified Sep 15, 2026.
Team · 10 people
from the firm's website & public directoriesFounder mafia
2 people who came through Accelmed Partners went on to found or lead other companies.
What they invest in
from 32 of 48 portfolio companiesHealthtech ×28Medical Devices ×27Digital Health ×12Biotech ×9Hardware ×8Robotics ×5E-commerce ×2FemTech ×2
HQs:United States×19Israel×3United Kingdom×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×62 founders×44+ founders×1
Investments · 48 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12022 · 22021 · 22020 · 12018 · 12015 · 12012 · 110 dated
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Digital HealthHardwareHealthtechMedical DevicesMountain View, US
Rebecca Kuhn(Executive Officer)inFrank Fischer(Executive Officer, Director)Vince Burgess(Director)Renee Ryan(Director)Ray Larkin(Director)Greg Garfield(Director)
Co-investorsNew Enterprise Associates (NEA)OrbiMed
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.
HealthtechMedical DevicesSports TechLondon, GB
Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin
Co-investorsAccess Venture PartnersAlphaDriveaMoonPeregrine VenturesTargeted Technology Funds
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inDavid Klein(Executive Officer, Director)inRandall Stanicky(Executive Officer)in
BoardAlex Zisson(Director)Lee Shapiro(Director)inCris De Luca(Director)in
Board seatUri Geiger· per SEC Form D
Co-investorsH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesSanofi VenturesSupernode Ventures+2 more
Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
BiotechTewksbury, US
George J. Fazio(Executive Officer, Director)inDan B. Curtis(Executive Officer)
BoardPaul LaViolette(Director)inKevin Gillis(Director)inGerald Brunk(Director)inIrit Yaniv(Director)
Board seatUri Geiger· per SEC Form D
Co-investorsGeneral CatalystLumira VenturesSV Health InvestorsThird Rock Ventures
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)
BoardMichael Carusi(Director)inArda Minocherhomjee(Director)
Board seatUri Geiger· per SEC Form D
Co-investorsCanaan PartnersEvidity Health CapitalLightstone VenturesVCFA GroupDe Novo VenturesFOUNDATION MEDICAL PARTNERS+1 more
MedMinder provides an integrated pharmacy, medication adherence, and connected care platform for healthcare providers, payors, and patients.
Digital HealthHardwareHealthtechMedical DevicesNorwood, US
TROY HILSENROTH(Executive Officer, Director)inEran Shavelsky(Executive Officer, Director)
BoardDANIEL COHEN(Director)Sundar Subramaniam(Director)Ben Dunn(Director)
Board seatUri Geiger· per SEC Form D
Strata Skin Sciences develops and provides dermatology treatment devices, including the XTRAC excimer laser and VTRAC excimer lamp for psoriasis and vitiligo, and the TheraClearX photopneumatic system for acne.
Advanced ManufacturingHardwareHealthtechMedical DevicesHorsham, US
Matthew Hill(CFO)Dolev Rafaeli(President & CEO)Samuel Rubinstein(Director)Samuel Navarro(Director)David Gill(Director)
Board seatUri Geiger· per SEC Form D
Aesthetic medical device company developing laser technologies for skin rejuvenation, with the UltraClear cold ablative laser.
Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures.
HardwareMedical DevicesWellness & Fitness
AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Sabina Chadha(Chief Executive Officer)inAnand Ramaswamy(Chief Product Officer)inJun Lu(VP of Engineering and AI)in
Co-investorsVIVE VCPalisades Growth CapitalTribeca Venture Partners
Dean Sysman(Founder)in
Co-investorsAccelALIVE Israel HealthTech FundAlkeon InnovationAlphaDriveBessemer Venture PartnersEmerge Ventures+5 more
Axora Medical develops minimally invasive hysteroscopy solutions for gynecologists to diagnose and treat intrauterine conditions such as polyps and fibroids in both office and operating room settings.
FemTechHealthtechMedical Devices
Moshe Geiger(Founder & Chairman)Darin Hammers(Chief Executive Officer)in
Bioness Medical develops neuromodulation systems, robotic systems, and software-based therapy programs for patients with central nervous system disorders and orthopedic injuries.
Digital HealthHealthtechMedical DevicesRobotics
Antonella Favit-Van Pelt(Chief Medical Officer)
Bioness Medical develops neuromodulation, robotic, and software-based medical technologies for patients with central nervous system disorders and orthopedic injuries.
BiotechDigital HealthMedical DevicesRobotics
Antonella Favit-Van Pelt(Chief Medical Officer)
U.S.-based global urology company (NASDAQ:CGNT); acquired by Laborie Medical Technologies in April 2018.
Co-investorsLumira Ventures
London, US
Sarim Siddiqui(Executive Officer, Director)Maroof Ahmed(Executive Officer, Director)Yusuf Sherwani(Executive Officer, Director)
Co-investorsManta Ray VenturesAtomicoH.I.G. BioHealth PartnersSanofi Ventures
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus.
BiotechHealthtechMedical Devices
Co-investorsPeregrine VenturesTal Ventures
Developed Plasma DR flat-panel X-ray detector technology; sold to Claymount in 2011.
Company commercializing endoscopic imaging systems, devices, and infection-control products for gastrointestinal specialists.
Co-investorsAgate Medical Investments LPRC Capital
Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy.
HealthtechMedical Devices
Kevin Mayberry(Chief Executive Officer)inGadi Divald(Chief Financial Officer)
Co-investorsSCP Vitalife Partners
Medical device company with a single-use hybrid catheter for precise material removal; acquired by AngioDynamics in 2019.
Boston, US
Evan Witt(Executive Officer, Director)Josh Tayloe(Executive Officer)
Co-investorsPeregrine VenturesTal Ventures
Zimmer Biomet is a medical device and digital health company committed to patient safety and product security across its portfolio.
Digital HealthHealthtechMedical DevicesRoboticsWarsaw, US
Co-investorsInnova Memphis, Inc.NaviMed CapitalInnova
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)inJames Leech(Executive Officer)inMatthew E. Likens(Executive Officer, Director)
BoardGeoff Pardo(Director)inPrattipati Laxminarain(Director)
Co-investorsFemHealth VenturesBlueStone Venture PartnersEvidity Health CapitalGilde HealthcareMedical Technology Venture PartnersMedTech Venture Partners+2 more
GT Medical Technologies develops GammaTile, an implantable radiation therapy device for treating operable brain tumors.
BiotechHealthtechMedical Devices
Co-investorsBlueStone Venture PartnersEvidity Health CapitalFemHealth Ventures
Keystone Dental develops wide-diameter dental implant systems for molar replacement, engineered to provide primary stability and preserve bone structure.
E-commerceHealthtechMedical DevicesBurlington, US
Tony Susino(Chief Executive Officer)inErez Cohen(Chief Operating Officer)Amnon Tamir(Chief Financial Officer)
Medical Compression Systems developed pneumatic compression therapy for DVT prevention; sold to Zimmer Biomet in 2017.
Momentis develops the Anovo Surgical System, a robotic surgery platform that supports a transvaginal, minimally-invasive approach with high articulation and reach.
HealthtechMedical DevicesRobotics
Co-investorsKrillion Ventures
Momentis Surgical develops the Anovo Surgical System, a robotic platform designed for minimally-invasive surgery using a transvaginal approach with articulated instruments.
FemTechHealthtechMedical DevicesRoboticsOr Yehuda
Dvir Cohen(Chief Executive Officer)inNataly Fellous(Vice President Finance)inSteven Nunes(Chief Commercial Officer)inHagai Berkovich(Chief Operations Officer)Noam Atar(Chief Financial Officer)in
BoardMorry Blumenfeld(Director)
Co-investorsPeregrine Ventures
Developed the NovaCross micro-catheter for complex coronary and peripheral vascular CTO; sold to MicroBot in 2022.
Nitinotes is an early-commercial-stage medical device company that makes EndoZip, an automated endoscopic suturing system for gastroplasty used to treat class I and II obesity in patients who do not qualify for traditional bariatric surgery.
HardwareHealthtechMedical DevicesCaesarea, IL
Co-investorsPeregrine Ventures
Developed minimally invasive surgical products for degenerative spinal conditions; sold to Seaspine in 2016.
Ophthalmic Imaging Systems provided ophthalmic imaging and informatics; acquired by Merge Healthcare (now IBM) in 2011.
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
Erez Golan(Founder)in
Co-investorsClal Biotechnology IndustriesIndaco Venture PartnersSofinnova Partners
Revamp Medical develops Doraya, a flow-reducing central venous catheter deployed in the infrarenal IVC to improve the efficacy of diuretic therapy in patients with acute heart failure.
HardwareHealthtechMedical DevicesNetanya, IL
SeaSpine, a spine surgery products company, has become part of Orthofix.
Medical Devices
SKNV is a compounding pharmacy that supplies customized dermatological medications formulated without common inactive ingredients and allergens, serving dermatology providers and their patients across the U.S.
Digital HealthE-commerceHealthtech
Spencer Malkin(CEO & Co-Founder)in
Co-investorsAndera PartnersNovaCapitalSupernova Invest
TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.
Digital HealthHealthtechSaaS
Adam Siton(Founder)inIsrael (Srulik) Dvorsky(Founder)in
Co-investorsAllumia VenturesBallad VenturesBridges IsraelOSF VenturesSamsung NextSanara Capital+2 more
HealthtechSan Diego, US
Wes Brazell(Executive Officer)Elias Vamvakas(Executive Officer, Director)
BoardAdrienne Graves(Director)Thomas Davidson, Jr.(Director)Richard Lindstrom(Director)Anthony Altig(Director)
Dry eye and IVD eyecare company (formerly TearLab) with the TearLab Osmolarity system; sold to Bausch+Lomb in 2024.
Company developing devices for minimally invasive heart valve disease treatment; Accelmed sold its holdings to TechWald in 2023.
Valcare Medical develops transcatheter solutions for treating mitral regurgitation, a structural heart condition, aiming to provide surgical-level durability without open-heart surgery.
Deep TechHealthtechMedical DevicesWilmington, US
Steve Sandweg(Chief Executive Officer)inDr. David Meerkin(Chief Medical Officer)Nadav Yellin(Chief Operating Officer)in
Veranex provides multi-disciplinary services to medical device and healthcare companies, supporting them from concept through commercialization of medical innovations.
BiotechDigital HealthHealthtechMedical DevicesRaleigh, US
Patrick K. Donnelly(Founder)inMegan Osorio(Chief Executive Officer)inJose Pablo Morales(Chief Medical Officer)inBeth Moeller(Chief Commercial Officer)inDavid Dockhorn(Chief Operating Officer)inManasi Ramanna(Chief Financial Officer)in
Co-investorsSummit PartnersLauxera Capital Partners
Exits · 2
IPOs and acquisitions across the tracked portfolioNeuroPaceNASDAQ: NPCESmith+NephewNYSE: SNN
Portfolio news
latest coverage across their companies
NeuroPace · stocktitan.net · Sep 1, 2026
GammaTile · dotmed.com · Jun 15, 2026
Endospan · massdevice.com · May 12, 2026
Click Therapeutics · mobihealthnews.com · Apr 17, 2026
Digital therapeutics · bhbusiness.com · Apr 2, 2025
Frequently asked questions
- How many investments has Accelmed Partners made?
- Accelmed Partners has 46 tracked investments, 2 of which have exited via acquisition or IPO.
- What stage does Accelmed Partners invest at?
- Accelmed Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Accelmed Partners focus on?
- Accelmed Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS.
- Where is Accelmed Partners located?
- Accelmed Partners is headquartered in Miami, US.
- Who does Accelmed Partners co-invest with?
- Accelmed Partners most often shares deals with Peregrine Ventures, AlphaDrive, Evidity Health Capital, among 55 tracked co-investors.
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.


















.png)






































.jpg)

.jpeg)